S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
2 Must-Have Silicon Companies That Don't Make Microchips
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Stocks to Benefit from the Aging Population
Small Caps That Have Priced In A Hard Landing For Big Upside
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
Interest rates will stay high 'as long as necessary,' the European Central Bank's leader says
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
3 Reasons Unity Software Is Ready to Rally 38%
Is Hanes Worth More than the Sum of Its Parts?
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
2 Must-Have Silicon Companies That Don't Make Microchips
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Stocks to Benefit from the Aging Population
Small Caps That Have Priced In A Hard Landing For Big Upside
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
Interest rates will stay high 'as long as necessary,' the European Central Bank's leader says
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
3 Reasons Unity Software Is Ready to Rally 38%
Is Hanes Worth More than the Sum of Its Parts?
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
2 Must-Have Silicon Companies That Don't Make Microchips
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Stocks to Benefit from the Aging Population
Small Caps That Have Priced In A Hard Landing For Big Upside
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
Interest rates will stay high 'as long as necessary,' the European Central Bank's leader says
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
3 Reasons Unity Software Is Ready to Rally 38%
Is Hanes Worth More than the Sum of Its Parts?
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
2 Must-Have Silicon Companies That Don't Make Microchips
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Stocks to Benefit from the Aging Population
Small Caps That Have Priced In A Hard Landing For Big Upside
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
Interest rates will stay high 'as long as necessary,' the European Central Bank's leader says
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
3 Reasons Unity Software Is Ready to Rally 38%
Is Hanes Worth More than the Sum of Its Parts?

ICU Medical (ICUI) Price Target & Analyst Ratings

$116.06
-0.39 (-0.33%)
(As of 09/25/2023 ET)
Compare
Today's Range
$114.55
$116.87
50-Day Range
$116.06
$178.18
52-Week Range
$114.55
$212.43
Volume
145,719 shs
Average Volume
181,960 shs
Market Capitalization
$2.80 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$216.00

ICU Medical Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 1 Analyst Ratings

Consensus Analyst Price Target

$216.00
86.11% Upside
High Prediction$216.00
Average Prediction$216.00
Low Prediction$216.00
TypeCurrent
9/26/22 to 9/26/23
1 Month Ago
8/27/22 to 8/27/23
3 Months Ago
6/28/22 to 6/28/23
1 Year Ago
9/26/21 to 9/26/22
Consensus Rating
Hold
Hold
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$216.00$216.00$203.00$207.50
Predicted Upside86.11% Upside17.37% Upside10.44% Upside11.62% Upside
Get ICU Medical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.


ICUI Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ICUI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

ICU Medical Stock vs. The Competition

TypeICU MedicalMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.66
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside86.11% Upside1,404.52% Upside628.20% Upside
News Sentiment RatingVery Positive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/9/202351job
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/9/2023KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$200.00 ➝ $216.00+17.37%
11/8/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
(Data available from 9/26/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












ICUI Price Target - Frequently Asked Questions

What is ICU Medical's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for ICU Medical stock is Hold based on the current 1 hold rating for ICUI. The average twelve-month price prediction for ICU Medical is $216.00 with a high price target of $216.00 and a low price target of $216.00. Learn more on ICUI's analyst rating history.

Do Wall Street analysts like ICU Medical more than its competitors?

Analysts like ICU Medical less than other Medical companies. The consensus rating for ICU Medical is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how ICUI compares to other companies.

Does ICU Medical's stock price have much upside?

According to analysts, ICU Medical's stock has a predicted upside of 17.37% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:ICUI) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -